Latest female sexual dysfunction Stories
Triggers euro 2.5 Million (~$3 Million) Milestone Payment from Gedeon Richter CRANBURY, N.J., Dec. 29, 2014 /PRNewswire/ -- Palatin Technologies, Inc.
Survey Results Released After the FDA's First Drug Development Public Workshop on Female Sexual Dysfunction RED BANK, N.J., Nov.
Even the Score Campaign Calls on FDA to Approve Medical Treatment Options for Female Sexual Dysfunction WASHINGTON, Oct.
CRANBURY, N.J. and BUDAPEST, Hungary, Sept. 3, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN; hereinafter: "Palatin") and Gedeon Richter Plc.
Persistent gender inequity at FDA has led to 26 approved drugs for men, and ZERO for women WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- Highlighting a persistent gender inequity at the
Data show many women are not aware of hypoactive sexual desire disorder and often blame themselves for symptoms of low desire RED BANK, N.J., May 20, 2014 /PRNewswire/ -- Nearly one
CRANBURY, N.J., May 6, 2014 /PRNewswire/ -- Palatin Technologies, Inc.
CRANBURY, N.J., April 29, 2014 /PRNewswire/ -- Palatin Technologies, Inc.
CRANBURY, N.J., March 31, 2014 /PRNewswire/ -- Palatin Technologies, Inc.
Data from first-in-class investigational treatment presented at the International Society for the Study of Women's Sexual Health (ISSWSH) Conference in San Diego CRANBURY, N.J., Feb.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.